Survival benefit of primary prevention implantable cardioverter‐defibrillator/cardiac resynchronization therapy with a defibrillator: Analysis of the Japan cardiac device treatment registry and Japanese cardiac registry of heart failure in cardiology

Documents similaires

• A novel prediction model for survival in individual patients with cardiac resynchronization therapy with a defibrillator: Analysis of the new Japan cardiac device treatment registry database
  par: Hisashi Yokoshiki, et autres
  Publié: (2025)
• Implantable cardiac defibrillator outcomes in octogenarians
  par: Bryan Stringer, et autres
  Publié: (2025)
• Return‐to‐play in athletes with transvenous and subcutaneous implantable cardiac defibrillator: A meta‐analysis
  par: Rifqi Rizkani Eri, et autres
  Publié: (2025)
• How to indicate implantable cardioverter‐defibrillator in the aging population
  par: Risako Orita, et autres
  Publié: (2025)
• Long‐term safety and efficacy of subcutaneous implantable cardioverter‐defibrillator compared with transvenous implantable cardioverter‐defibrillator in propensity score‐matched patients from Japan
  par: Yuki Konno, et autres
  Publié: (2025)